West NR - Search Results

1

The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer.

Spowart JE, Townsend KN, Huwait H, Eshragh S, West NR, Ries JN, Kalloger S, Anglesio M, Gorski SM, Watson PH, Gilks CB, Huntsman DG, Lum JJ. Spowart JE, et al. Among authors: west nr. J Pathol. 2012 Dec;228(4):437-47. doi: 10.1002/path.4090. J Pathol. 2012. PMID: 22926683

2

Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.

Townsend KN, Spowart JE, Huwait H, Eshragh S, West NR, Elrick MA, Kalloger SE, Anglesio M, Watson PH, Huntsman DG, Lum JJ. Townsend KN, et al. Among authors: west nr. PLoS One. 2013 Dec 23;8(12):e82406. doi: 10.1371/journal.pone.0082406. eCollection 2013. PLoS One. 2013. PMID: 24376535 Free PMC article.

3

S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.

West NR, Watson PH. West NR, et al. Oncogene. 2010 Apr 8;29(14):2083-92. doi: 10.1038/onc.2009.488. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101226

4

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.

West NR, Murray JI, Watson PH. West NR, et al. Oncogene. 2014 Mar 20;33(12):1485-94. doi: 10.1038/onc.2013.105. Epub 2013 Apr 15. Oncogene. 2014. PMID: 23584474

5

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.

West NR, Murphy LC, Watson PH. West NR, et al. Endocr Relat Cancer. 2012 Apr 10;19(2):181-95. doi: 10.1530/ERC-11-0326. Print 2012 Apr. Endocr Relat Cancer. 2012. PMID: 22267707

6

Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.

Wang J, Barnes RO, West NR, Olson M, Chu JE, Watson PH. Wang J, et al. Among authors: west nr. Breast Cancer Res. 2008;10(3):R51. doi: 10.1186/bcr2105. Epub 2008 Jun 6. Breast Cancer Res. 2008. PMID: 18534028 Free PMC article.

7

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

West NR, Milne K, Truong PT, Macpherson N, Nelson BH, Watson PH. West NR, et al. Breast Cancer Res. 2011;13(6):R126. doi: 10.1186/bcr3072. Epub 2011 Dec 8. Breast Cancer Res. 2011. PMID: 22151962 Free PMC article.

8

Intratumoural inflammation and endocrine resistance in breast cancer.

Murray JI, West NR, Murphy LC, Watson PH. Murray JI, et al. Among authors: west nr. Endocr Relat Cancer. 2015 Feb;22(1):R51-67. doi: 10.1530/ERC-14-0096. Epub 2014 Nov 17. Endocr Relat Cancer. 2015. PMID: 25404688 Review.

9

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

West NR, Kost SE, Martin SD, Milne K, Deleeuw RJ, Nelson BH, Watson PH. West NR, et al. Br J Cancer. 2013 Jan 15;108(1):155-62. doi: 10.1038/bjc.2012.524. Epub 2012 Nov 20. Br J Cancer. 2013. PMID: 23169287 Free PMC article.

10

Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.

West NR, Farnell B, Murray JI, Hof F, Watson PH, Boulanger MJ. West NR, et al. Protein Sci. 2009 Dec;18(12):2615-23. doi: 10.1002/pro.274. Protein Sci. 2009. PMID: 19844956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters